Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer

Related articles

1. Targeting CALR with a small molecule for the treatment of gastric cancer

   This article has 16 authors:

   1. Lina Wang
   2. Lulu Li
   3. Chunmei Wu
   4. Qingfeng Li
   5. Yiyuqing Yang
   6. Huamin Liu
   7. Yang Xiang
   8. Hui Huang
   9. Chenghong Li
   10. Shuang Xu
   11. Yimei Li
   12. Pengfei Zheng
   13. Ting Yu
   14. Jun Chen
   15. Hongming Miao
   16. Junsong Zheng

2. CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer

   This article has 14 authors:

   1. Yu Yan
   2. Athira Narayan
   3. Marzieh Mazinani
   4. Harumi Saeki
   5. Tao Huang
   6. Gabi Lofland
   7. Edward Gabrielson
   8. Leslie Cope
   9. Yasmine Kanaan
   10. Ali Afsari
   11. Tammey Naab
   12. Saraswati Sukumar
   13. Martin Pomper
   14. Vanessa Merino

3. Targeting of a novel interplay between MET Tyrosine Kinase and NRF2 enhances sensitivity to Paclitaxel in Triple Negative Breast Cancer

   This article has 14 authors:

   1. Irene Taddei
   2. Claudia Cirotti
   3. Fabienne Lamballe
   4. Olivier Castellanet
   5. Flavio Maina
   6. Vanessa Medici
   7. Fabrizio Fierro
   8. Giacomo Corleone
   9. Francesca De Nicola
   10. Maurizio Fanciulli
   11. Eleonora Cesari
   12. Alba Di Leone
   13. Claudio Sette
   14. Daniela Barilà